Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results

Go back to Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results

DexCom (DXCM) Misses Q4 EPS by 1c, Offers FY Guidance

February 11, 2021 4:48 PM EST

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.91, $0.01 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $568.9 million versus the consensus estimate of $554.7 million.

GUIDANCE:

DexCom sees FY2021 revenue of $2.21-2.31 billion.

Non-GAAP Gross profit margin of... More